Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Population characteristics. RPS São Luís (N = 2515)

From: High free sugars, insulin resistance, and low socioeconomic indicators: the hubs in the complex network of non-communicable diseases in adolescents

 

Overall

Male

Female

p-value

Adolescent education

   

0.160

 High school or more

2486 (98.9)

1177 (47.5)

1301 (52.5)

 

 Elementary school or less

27 (1.1)

17 (63.0)

10 (37.0)

 

Family head education

   

0.011

 High school or more

1919 (76.5)

942 (49.1)

977 (50.9)

 

 Elementary school or less

588 (23.5)

253 (43.0)

335 (57.0)

 

Household income

   

1.00

  > USD 270.76

1214 (54.2)

575 (47.5)

635 (52.5)

 

  ≤ USD 270.76

1026 (45.8)

486 (47.5)

537 (52.5)

 

Socioeconomic class

   

0.018

 A/B

654 (29.5)

334 (51.2)

318 (48.8)

 

 C/D/E

1560 (70.5)

709 (45.6)

845 (54.4)

 

Smoking

   

 < 0.001

 No

2407 (96.5)

1127 (46.8)

1280 (53.2)

 

 Yes

88 (3.5)

61 (69.3)

27 (30.7)

 

Alcohol use

   

 < 0.001

 No

2026 (80.7)

905 (44.8)

1116 (55.2)

 

 Yes

486 (19.3)

290 (59.7)

196 (40.3)

 

Drug use

   

 < 0.001

 No

2030 (82.1)

913 (45.0)

1117 (55.0)

 

 Yes

443 (17.9)

264 (59.6)

179 (40.4)

 

Sutured fat consumptiona

   

 < 0.001

  < 10%

1819 (72.8)

935 (51.4)

884 (48.6)

 

  ≥ 10%

680 (27.2)

254 (37.4)

426 (62.6)

 

Lipids consumptiona

   

 < 0.001

  < 30%

2249 (90.0)

1102 (49.0)

1147 (51.0)

 

  ≥ 30%

250 (10.0)

87 (34.8)

163 (65.2)

 

Free sugar consumption

    

  < 5%a

6 (0.2)

5 (83.3)

1 (16.7)

0.178

  ≥ 5%

2493 (99.8)

1184 (47.5)

1309 (52.5)

 

  < 10%a

56 (2.2)

29 (51.8)

27 (48.2)

0.616

  ≥ 10%

2443 (97.8)

1160 (47.5)

1283 (52.5)

 

  < 25 gb

25 (1.0)

14 (56.0)

11 (44.0)

0.524

  ≥ 25 g

2482 (99.0)

1181 (47.6)

1301 (52.4)

 

Sodium consumption

   

0.230

 < 5 g

2415 (96.3)

1145 (47.4)

1270 (52.6)

 

  ≥ 5 g

92 (3.7)

50 (54.3)

42 (45.7)

 

Protein consumptionc

   

0.950

  ≥ 0.8 g/kg

1734 (70.5)

833 (48.0)

901 (52.0)

 

  < 0.8 g/kg

725 (29.5)

350 (48.3)

375 (51.7)

 
    

0.690

  ≤ 2.0 g/kg

2227 (90.6)

1068 (48.0)

1159 (52.0)

 

  > 2.0 g/kg

232 (9.4)

115 (49.6)

117 (50.4)

 

Fiber consumption

   

 < 0.001

  ≥ 25 g for women; ≥ 38 g for men

1446 (58.0)

558 (38.6)

886 (61.4)

 

  < 25 g for women; < 38 g for men

1049 (42.0)

634 (60.4)

415 (39.6)

 

Body mass index

   

0.530

 Eutrophic

2002 (81.0)

962 (48.1)

1040 (51.9)

 

 Overweight/Obesity

370 (15.0)

169 (45.7)

201 (54.3)

 

Blood pressure

   

 < 0.001

  < 130/80 mgHg

2055 (83.3)

882 (43.0)

1168 (57.0)

 

  ≥ 130/80 mgHg

413 (16.7)

302 (73.1)

111 (26.9)

 

PWVd

   

 < 0.001

  < 90th percentile

1983 (89.0)

920 (46.5)

1058 (53.5)

 

  ≥ 90th percentile

245 (11.0)

153 (62.4)

92 (37.6)

 

Body fat

   

 < 0.001

  < 30% for women; < 25% for men

1810 (73.5)

1059 (58.7)

745 (41.3)

 

  ≥ 30% for women; ≥ 25% for men

652 (26.5)

121 (18.6)

531 (81.4)

 

Total cholesterol

   

 < 0.001

  < 200 mg/dL

2071 (90.1)

1034 (50.1)

1029 (49.9)

 

  ≥ 200 mg/dL

228 (9.9)

73 (32.0)

155 (68.0)

 

LDL-c

   

0.001

  < 130 mg/dL

2107 (92.0)

1041 (49.4)

1066 (50.6)

 

  ≥ 130 mg/dL

184 (8.0)

67 (36.4)

117 (63.6)

 

VLDL-c

   

0.002

  < 30 mg/dL

2089 (90.9)

984 (47.3)

1097 (52.7)

 

  ≥ 30 mg/dL

209 (9.1)

123 (58.9)

86 (41.1)

 

Triglycerides

   

 < 0.001

  < 150 mg/dL

2088 (91.1)

985 (47.2)

1103 (52.8)

 

  ≥ 150 mg/dL

203 (8.9)

123 (60.6)

80 (39.4)

 

HDL-c

   

 < 0.001

  ≥ 40 mg/dL

1834 (80.0)

782 (42.6)

1052 (57.4)

 

  < 40 mg/dL

458 (20.0)

326 (71.2)

132 (28.8)

 

Triglycerides/ HDL-c

   

 < 0.001

  < 1.75

1471 (59.2)

584 (39.8)

882 (60.2)

 

  ≥ 1.75

1014 (40.8)

599 (59.2)

412 (40.8)

 

TyG index

   

0.688

  < 7.94

634 (27.7)

307 (48.7)

324 (51.3)

 

  ≥ 7.94

1653 (72.3)

785 (47.6)

864 (52.4)

 

Asthma

   

0.040

 No

2209 (88.7)

1035 (46.9)

1174 (53.1)

 

 Yes

282 (11.3)

151 (53.5)

131 (46.5)

 

FEV1e

   

 < 0.001

  > 80%

1485 (66.1)

758 (51.0)

727 (49.0)

 

  ≤ 80%

762 (33.9)

316 (41.5)

446 (58.5)

 

Depression

   

 < 0.001

 No

2135 (85.7)

1089 (51.0)

1046 (49.0)

 

 Yes

356 (14.3)

97 (27.2)

259 (72.8)

 

Suicide risk

   

 < 0.001

 1–5 score

2368 (94.5)

1155 (48.8)

1213 (51.2)

 

  ≥ 6 score

139 (5.5)

40 (28.8)

99 (71.2)

 

Physical activity

   

 < 0.001

  ≥ 150 min

1377 (55.2)

892 (64.8)

485 (35.2)

 

  < 150 min

1117 (44.8)

295 (26.4)

822 (73.6)

 

Sleep quality

   

 < 0.001

 Good

977 (46.3)

527 (53.9)

450 (46.1)

 

 Poor

1133 (53.7)

471 (41.6)

662 (58.4)

 

Sleepiness

   

 < 0.001

 No

1582 (63.2)

808 (51.1)

774 (48.9)

 

 Yes

920 (36.8)

383 (41.6)

537 (58.4)

 

Caries

   

0.565

 No

1054 (44.1)

492 (46.8)

559 (53.2)

 

 Yes

1336 (55.9)

640 (48.1)

691 (51.9)

 

Severe caries

   

0.220

 No

1459 (73.5)

688 (47.3)

766 (52.7)

 

 Yes

527 (26.5)

265 (50.6)

259 (49.4)

 

Periodontitis

   

0.013

 No

1548 (65.0)

710 (46.0)

835 (54.0)

 

 Yes

832 (35.0)

426 (51.4)

403 (48.6)

 

Bleeding on probingf

   

0.706

  < 15%

1352 (56.8)

640 (47.5)

708 (52.5)

 

  ≥ 15%

1028 (43.2)

496 (48.3)

530 (51.7)

 
  1. The p-value was obtained from the Chi-squared test to observe differences between the sexes at a significance level of 5%. Totals may vary due to missing data for some variables
  2. a% of total daily calories
  3. bgrams per day
  4. cConsumption in grams in relation to body weight
  5. dPWV: Pulse wave velocity
  6. eFEV1: Forced expiratory volume in the first second
  7. f% of sites affected in comparison to the total evaluated